Streetbeat News

Stock Prices

ARMK

Aramark (NYSE:ARMK) has received one somewhat bullish and four indifferent analyst ratings in the last quarter. The average 12-month price target for the company, according to five analysts, is $43.6, a 9.0% increase from the previous average of $40.00.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 8:00 pm

CRBG

In the last quarter, Corebridge Financial (NYSE:CRBG) received a mix of bullish and indifferent ratings from analysts. The company's average 12-month price target is $22.89, a decrease of 7.22% from the previous average of $24.67. Analysts base their ratings on company financial statements, conference calls, meetings, and insider information.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 8:00 pm

INTC

Intel Corporation (NASDAQ:INTC) shares moved higher on Monday ahead of its Q2 2023 financial results announcement on July 27. The company's stock has seen activity in the past month with several price target changes ranging from $17 to $39. China's restrictions on the export of metals used in chip production also impacted semiconductor and chip companies, including Intel.

Portfolio Pulse from Ryan Gustafson

July 17, 2023 | 8:00 pm

ARRY

Over the past 3 months, 8 analysts have published their opinion on Array Technologies (NASDAQ:ARRY) stock. The average price target for the stock has increased by 7.73% from the previous average price target of $24.83 to $26.75. The high price target is $37.00 and the low is $16.00. The ratings are generally bullish with 3 bullish, 4 somewhat bullish, and 1 somewhat bearish.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 8:00 pm

MET

Analysts have provided bullish ratings for MetLife (NYSE:MET) within the last quarter, with an average price target of $75.0 versus the current price of $59.145. This current average has decreased by 3.99% from the previous average price target of $78.12.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 8:00 pm

GILD

Gilead Sciences Inc.'s (NASDAQ:GILD) share price is currently at $77.52, after a 0.42% increase. Over the past month, the stock fell by 0.25%, but it spiked by 24.78% in the past year. The company's P/E ratio of 17.46 is lower than the Biotechnology industry average of 48.76, which could indicate that the stock is undervalued or that shareholders do not expect future growth.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 8:00 pm

ACDC

ProFrac Holding (NASDAQ:ACDC) has received mostly bullish ratings from analysts in the last quarter, with an average price target of $18.6, a decrease of 17.7% from the previous average price target of $22.60. The ratings are based on research of company financial statements, conference calls, meetings, and insider information.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 8:00 pm

COIN

TSLA

In a recent interview on Bloomberg TV, Cathie Wood, the founder of ARK Invest, expressed her positive outlook on Coinbase (COIN) following a ruling on Ripple. She also mentioned Tesla (TSLA) as the biggest AI opportunity.

Portfolio Pulse from Happy Mohamed

July 17, 2023 | 7:58 pm

FSR

Fisker Inc. has announced plans to produce 100 Fisker Extreme Vigyan Edition all-electric SUVs for the Indian market. This news has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 7:56 pm

SPY

The market on close imbalance is leaning towards the sell-side with a $1B imbalance. This could potentially impact the SPY ETF.

Portfolio Pulse from Happy Mohamed

July 17, 2023 | 7:52 pm